Global Cord Blood Corp

NYSE:CO   3:59:50 PM EDT
3.19
-0.14 (-4.20%)
Products

Global Cord Blood Corporation Announced Cellenkos Receives FDA Clearance Of IND Application For CK0804

Published: 06/16/2022 21:24 GMT
Global Cord Blood Corp (CO) - Global Cord Blood Corporation Announced Cellenkos Receives FDA Clearance of Ind Application for Ck0804 As Add on Therapy to Ruxolitinib for the Treatment of Myelofibrosis.